Integer Holdings Corporation $ITGR Shares Sold by Great Lakes Advisors LLC

Great Lakes Advisors LLC lowered its holdings in Integer Holdings Corporation (NYSE:ITGR) by 72.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 31,351 shares of the medical equipment provider’s stock after selling 82,834 shares during the quarter. Great Lakes Advisors LLC’s holdings in Integer were worth $3,239,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. State Street Corp boosted its holdings in Integer by 1.0% in the second quarter. State Street Corp now owns 1,326,050 shares of the medical equipment provider’s stock valued at $163,064,000 after purchasing an additional 13,540 shares in the last quarter. Viking Global Investors LP lifted its position in shares of Integer by 9.1% during the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock worth $157,889,000 after buying an additional 106,692 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Integer by 885.1% in the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after buying an additional 993,810 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Integer by 11.5% in the 2nd quarter. Franklin Resources Inc. now owns 907,232 shares of the medical equipment provider’s stock valued at $111,562,000 after buying an additional 93,294 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Integer by 3.9% during the 2nd quarter. Geode Capital Management LLC now owns 819,089 shares of the medical equipment provider’s stock worth $100,736,000 after acquiring an additional 31,026 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ITGR. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Piper Sandler reduced their target price on Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Argus cut Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. KeyCorp cut their price target on Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $95.00 price objective (down previously from $143.00) on shares of Integer in a research note on Friday, October 24th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $98.38.

Trending Headlines about Integer

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Multiple firms announce a securities-fraud class action against Integer covering investors who bought shares between July 25, 2024 and October 22, 2025; plaintiffs allege misleading statements and seek lead plaintiff appointments. Integer Accused of Misleading Investors — GlobeNewswire
• Negative Sentiment: Numerous plaintiff firms (Rosen, Levi & Korsinsky, Bernstein Liebhard, Pomerantz, et al.) are soliciting lead plaintiff candidates and reminding investors of a February 9, 2026 deadline to file — increasing the likelihood of consolidated litigation and legal costs. Rosen Law Firm Deadline Notice — Newsfile
• Negative Sentiment: Lawyer notices link the litigation to a prior ~32% share plunge that triggered investor losses; that drop is the proximate cause for the suits and is cited repeatedly in firm announcements. Loss Notice: Plummeted 32% — Newsfile

Integer Stock Performance

NYSE ITGR opened at $86.87 on Friday. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $144.76. The business’s 50-day moving average price is $78.46 and its 200 day moving average price is $90.90. The firm has a market cap of $3.04 billion, a P/E ratio of 36.35, a P/E/G ratio of 0.79 and a beta of 0.78.

Integer announced that its board has approved a stock buyback program on Tuesday, November 4th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to buy up to 8.3% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other Integer news, VP Tommy P. Thomas sold 884 shares of Integer stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total value of $62,012.60. Following the transaction, the vice president directly owned 3,596 shares in the company, valued at approximately $252,259.40. This trade represents a 19.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Cheryl C. Capps bought 1,600 shares of the company’s stock in a transaction dated Thursday, November 6th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $106,720.00. Following the acquisition, the director owned 11,702 shares of the company’s stock, valued at approximately $780,523.40. This trade represents a 15.84% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 2.16% of the stock is owned by insiders.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.